SCHEMBL4927312

SCHEMBL4927312

CC(C)=CCc1c(N)ccc2c(C)cc(=O)oc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE4D Q08499 2/20 0.52
▸ GAA P10253 5/20 0.51
▸ HSD17B10 Q99714 3/20 0.51
▸ GFER P55789 1/20 0.51
▸ ABCB1 P08183 1/20 0.50
▸ ERN1 O75460 1/20 0.47
▸ KDM4E B2RXH2 5/20 0.47
▸ ALDH1A1 P00352 3/20 0.47
▸ MAPT P10636 2/20 0.47
▸ MAPK1 P28482 2/20 0.47
▸ MAOB P27338 2/20 0.47
▸ MCL1 Q07820 2/20 0.47
▸ MGAM O43451 1/20 0.47
▸ LMNA P02545 1/20 0.47
▸ TP53 P04637 1/20 0.47
▸ CYP3A4 P08684 1/20 0.47
▸ SI P14410 1/20 0.47
▸ ALOX15 P16050 1/20 0.47
▸ MGAM2 Q2M2H8 1/20 0.47
▸ ERAP1 Q9NZ08 3/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4931168 0.80 PDE4D (0.43) PDE4DGAAHSD17B10KDM4EALDH1A1
SCHEMBL4929255 0.80 HSD17B10 (0.55) GAAHSD17B10GFERERN1KDM4E
SCHEMBL4928161 0.72 MAOA (0.47) PDE4DGAAHSD17B10ABCB1KDM4E
SCHEMBL3878331 0.70 CA9 (0.65) GAAHSD17B10GFERERN1KDM4E
SCHEMBL14088020 0.70 PDE4D (0.46) PDE4DGAAHSD17B10ABCB1KDM4E
SCHEMBL8807829 0.70 HSD17B10 (0.56) GAAHSD17B10GFERERN1KDM4E
SCHEMBL17716513 0.69 HSD17B10 (0.55) GAAHSD17B10GFERERN1KDM4E
SCHEMBL18155873 0.69 KDM4E (0.67) GAAHSD17B10GFERERN1KDM4E
SCHEMBL16341040 0.68 PDE4D (1.00) PDE4DHSD17B10ABCB1KDM4EALDH1A1
SCHEMBL6901789 0.68 KDM4E (0.74) GAAHSD17B10KDM4EALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080194522-A1 Development of Fluorogenic Substrates For Monoamine Oxidases (Mao-A and Mao-B) TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, THE 2008-08-14 — — US disclosed
US-20080194522-A1 Development of Fluorogenic Substrates For Monoamine Oxidases (Mao-A and Mao-B) TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, THE 2008-08-14 — — US disclosed
US-20080194522-A1 Development of Fluorogenic Substrates For Monoamine Oxidases (Mao-A and Mao-B) TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, THE 2008-08-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080194522-A1 Development of Fluorogenic Substrates For Monoamine Oxidases (Mao-A and Mao-B) MAOA, MAOB, COMT PDE4D 430/4885GAA 67/4885HSD17B10 336/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback